The conundrum of neuroprotection in Parkinson's disease

Affiliations

Comment

Angelo Antonini. Lancet Neurol. 2011 May.

. 2011 May;10(5):396-7.

doi: 10.1016/S1474-4422(11)70078-3. Epub 2011 Apr 7.

¹ Department for Parkinson's disease, IRCCS San Camillo, Venice 30126, Italy. angelo3000@yahoo.com

No abstract available

Comment on

A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
Rascol O, Fitzer-Attas CJ, Hauser R, Jankovic J, Lang A, Langston JW, Melamed E, Poewe W, Stocchi F, Tolosa E, Eyal E, Weiss YM, Olanow CW. Rascol O, et al. Lancet Neurol. 2011 May;10(5):415-23. doi: 10.1016/S1474-4422(11)70073-4. Epub 2011 Apr 7. Lancet Neurol. 2011. PMID: 21482191 Clinical Trial.

Biomarkers for trials of neuroprotection in Parkinson's disease.
Agarwal PA, Stoessl AJ. Agarwal PA, et al. Mov Disord. 2013 Jan;28(1):71-85. doi: 10.1002/mds.25065. Epub 2012 Aug 24. Mov Disord. 2013. PMID: 22927101 Review.
Neuroprotection in Parkinson's disease: an elusive goal.
Biglan KM, Ravina B. Biglan KM, et al. Semin Neurol. 2007 Apr;27(2):106-12. doi: 10.1055/s-2007-971168. Semin Neurol. 2007. PMID: 17390255 Review.
[Neuroprotection in Parkinson's disease: analysis though group of experts' methodology].
Linazasoro G, Sesar A, Valldeoriola F, Compta Y, Herrero MT, Martínez Castrillo JC, López Lozano JJ, Bergaretxe A, Vela L, Fernández JM, Castro A, Kulisevski J, Lezcano E, Vaamonde J, López Del Val J, Chacón J, Vivancos F, Luquin R, Aguilar M, Burguera JA, Salvador C, Menéndez Guisasola L, Catalán MJ, Mir P, Campos V, Grandas F, Mínguez A, Balaguer E, Yáñez R, Leiva C, García Ruiz P, Cubo E. Linazasoro G, et al. Neurologia. 2009 Mar;24(2):113-24. Neurologia. 2009. PMID: 19322690 Spanish.
The six gaps in the search of neuroprotection for Parkinson's disease.
Espay AJ, Fasano A, Morgante F. Espay AJ, et al. Expert Rev Neurother. 2012 Feb;12(2):111-3. doi: 10.1586/ern.11.202. Expert Rev Neurother. 2012. PMID: 22288665 No abstract available.
Discovering neuroprotection in Parkinson's disease, or getting to haphazard.
Kieburtz K. Kieburtz K. Mt Sinai J Med. 2010 Nov-Dec;77(6):700-6. doi: 10.1002/msj.20219. Mt Sinai J Med. 2010. PMID: 21105130